Caribou Biosciences Inc. (CRBU)
1.56
0.00 (0.00%)
At close: Jan 15, 2025, 3:59 PM
1.63
4.15%
After-hours Jan 15, 2025, 04:01 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -4.14 | -3.84 | -13.59 | -28.53 | -41.77 |
| PS Ratio | 12.27 | 27.57 | 94.75 | 79.18 | 169.10 |
| PB Ratio | 1.15 | 1.27 | 2.34 | -41.76 | 131.14 |
| P/FCF Ratio | -4.03 | -3.9 | -25.52 | -28.34 | -29.76 |
| P/OCF Ratio | -4.53 | -4.2 | -27.96 | -29.47 | -30.58 |
| OCF/S Ratio | -2.71 | -6.57 | -3.39 | -2.69 | -5.53 |
| Debt / Equity Ratio | 0.07 | 0.09 | 0.00 | -0.07 | 0.07 |
| Quick Ratio | 11.97 | 11.48 | 16.35 | 1.77 | 5.34 |
| Current Ratio | 11.97 | 9.25 | 15.15 | 1.96 | 5.66 |
| Asset Turnover | 0.08 | 0.04 | 0.02 | 0.34 | 0.09 |
| Interest Coverage | n/a | n/a | -8.37K | -1.81K | -8.58K |
| Return on Equity (ROE) | -0.28 | -0.33 | -0.17 | 1.46 | -3.14 |
| Return on Assets (ROA) | -0.24 | -0.27 | -0.15 | -0.95 | -0.38 |
| Return on Capital (ROIC) | -0.29 | -0.31 | -0.16 | -1.53 | -0.66 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -225.07% | 73.71% | 89.75% | -178.5% | -308.34% |
| Net Profit Margin | -296.05% | -717.79% | -697.26% | -277.55% | -404.82% |
| Pretax Profit Margin | -295.49% | -717.28% | -693.92% | -292.27% | -535.04% |
| Operating Profit Margin | -336.63% | -768.17% | -697.84% | -292.24% | -592.69% |
| FCF Margin | -304.27% | -707.67% | -371.33% | -279.35% | -568.24% |
| EBITDA Margin | -326.4% | -756.46% | -687.59% | -284.82% | -521.99% |